These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 25455844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer care.
    Ng W, Delaney GP, Jacob S, Barton MB.
    Eur J Cancer; 2010 Mar; 46(4):703-12. PubMed ID: 20034784
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care.
    Jacob S, Ng W, Asghari R, Delaney GP, Barton MB.
    Eur J Cancer; 2009 Sep; 45(14):2503-9. PubMed ID: 19527926
    [Abstract] [Full Text] [Related]

  • 5. Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-based benchmark for cancer care.
    Jacob S, Hovey E, Ng W, Vinod S, Delaney GP, Barton MB.
    Lung Cancer; 2010 Sep; 69(3):307-14. PubMed ID: 20080315
    [Abstract] [Full Text] [Related]

  • 6. Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care.
    Jacob S, Ng W, Delaney GP, Barton MB.
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):48-54. PubMed ID: 20951557
    [Abstract] [Full Text] [Related]

  • 7. Chemotherapy in rectal cancer: variation in utilization and development of an evidence-based benchmark rate of optimal chemotherapy utilization.
    Jacob S, Ng W, Asghari R, Delaney GP, Barton MB.
    Clin Colorectal Cancer; 2011 Jun; 10(2):102-7. PubMed ID: 21859561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients.
    Jacob S, Wong K, Delaney GP, Adams P, Barton MB.
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):56-64. PubMed ID: 19969443
    [Abstract] [Full Text] [Related]

  • 10. Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer.
    Fong A, Ng W, Barton MB, Delaney GP.
    Breast; 2010 Oct; 19(5):345-9. PubMed ID: 20223666
    [Abstract] [Full Text] [Related]

  • 11. Evidence-based estimates of the demand for radiotherapy.
    Delaney GP, Barton MB.
    Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):70-6. PubMed ID: 25455408
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.
    Delaney G, Barton M, Jacob S.
    Cancer; 2004 Aug 15; 101(4):657-70. PubMed ID: 15305395
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II--carcinoma of the endometrium.
    Delaney G, Jacob S, Barton M.
    Cancer; 2004 Aug 15; 101(4):682-92. PubMed ID: 15305397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.